Clover Health Investments, CORP /DE Form 4 insider transactions

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 32,416 shares of Class A Common Stock on July 18, 2024, to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 5,388 shares of Class A Common Stock on July 3, 2024, to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, reports the vesting of restricted stock units and associated tax withholding on June 30, 2024.

Aric Sharp, CEO of Value Based Care at Clover Health, reports the acquisition and disposal of Class A Common Stock due to vesting of restricted stock units and tax obligations.

Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., purchased 877,567 shares of Class A Common Stock at a weighted average price of $1.14 on June 17, 2024.

Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 4,499 shares of Class A Common Stock on June 15, 2024, to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Clover Health, reports the disposal of Class A Common Stock to cover tax obligations related to vesting of Restricted Stock Units (RSUs).

Clover Health's Chief Technology Officer, Conrad Wai, disposed of 69,148 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Anna U. Loengard, a director at Clover Health Investments Corp., reported the acquisition of Class A Common Stock through various accounts, including spousal and children's IRAs and custodial accounts.

Karen Soares, General Counsel & Secretary of Clover Health Investments, sold shares to cover tax obligations upon the vesting of restricted stock units.

Aric Sharp, CEO of Value Based Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of 85,367 shares of Class A Common Stock on May 8, 2024, to cover tax obligations related to vesting restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 32,416 shares of Class A Common Stock on April 18, 2024, to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 5,387 shares of Class A Common Stock on April 3, 2024, to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health, reports the disposal of 5,378 shares of Class A Common Stock to cover tax obligations upon RSU vesting.

Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 5,168 shares of Class A Common Stock on March 15, 2024, to cover tax obligations related to vesting restricted stock units.

Clover Health's Chief Technology Officer, Conrad Wai, disposed of shares to cover tax obligations arising from the vesting of restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 7,777 shares of Class A Common Stock to cover tax obligations upon the vesting of restricted stock units (RSUs).

Director Anna U. Loengard reports purchasing 137,000 shares of Clover Health Investments, Corp. at an average price of $0.73 per share.